Safinamide in Parkinson's disease: No hint of added benefit

Wednesday, August 19, 2015 - 10:30 in Health & Medicine

Regarding Safinamide in Parkinson's disease, reviewers state that since since relevant study data were not considered, analyses in the dossier were incomplete regarding serious side effects in the comparator therapy, long-term data and other aspects.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net